Clinical Trial Update: Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy of albendazole for treating intestinal helminth infections and investigated its impact on gut microflora.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helminthiasis

Drugs mentioned

• Albendazole (ALBENDAZOLE)

Snippet

Sponsor: Albert Schweitzer Hospital | Conditions: Intestinal Diseases, Helminthiasis | Phase 4 | Status: COMPLETED